Vermillion Inc (VRML)

1.27
NASDAQ : Health Care
Prev Close 1.27
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.76 / 2.85
Avg Volume 43.40K
Exchange NASDAQ
Shares Outstanding 56.16M
Market Cap 69.64M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

This Labor Day Weekend, Talk to Every Woman You Know About Ovarian Cancer

This Labor Day Weekend, Talk to Every Woman You Know About Ovarian Cancer

The biggest challenge to ovarian cancer diagnostic care is awareness, according to Valerie Palimeri, CEO of Vermillion.

Vermillion Announces Publication Of First OVA1® Clinical Utility Study

Vermillion Announces Publication Of First OVA1® Clinical Utility Study

Nearly all of the patients who had primary ovarian malignancies were appropriately referred to gynecologic oncologists, highlighting the clinical utility of OVA1

Vermillion Receives $2 Million Disbursement Of Up To $4 Million Loan From The Connecticut Department Of Economic And Community Development

Vermillion Receives $2 Million Disbursement Of Up To $4 Million Loan From The Connecticut Department Of Economic And Community Development

Proceeds from Low Interest Loan to be Primarily Utilized to Fund Build-Out of Vermillion's Trumbull, CT Facility Including Investment in Laboratory and Information Technology Infrastructure

6 Oil Stocks to Watch as Oil Remains Volatile

6 Oil Stocks to Watch as Oil Remains Volatile

Oil prices remain volatile, and investors should remain cautious when investing in the sector. Here are 6 stocks recommended by BMO Capital Markets.

3 Stocks Boosting The Drugs Industry Higher

3 Stocks Boosting The Drugs Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Drugs Stocks Pushing The Industry Higher

3 Drugs Stocks Pushing The Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Driving The Drugs Industry Higher

3 Stocks Driving The Drugs Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

Faruqi & Faruqi, LLP Launches An Investigation Against Vermillion, Inc. (VRML) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Faruqi & Faruqi, LLP Launches An Investigation Against Vermillion, Inc. (VRML) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Vermillion, Inc.

4 Stocks Under $10 Spiking Higher

4 Stocks Under $10 Spiking Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

Keep these under-$10 stocks on your radar.

Vermillion Management Discusses Q2 2012 Results - Earnings Call Transcript

Vermillion Management Discusses Q2 2012 Results - Earnings Call Transcript

Vermillion Management Discusses Q2 2012 Results - Earnings Call Transcript

7 Stocks Under $10 Soaring Higher

7 Stocks Under $10 Soaring Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Soaring in a Weak Market

7 Stocks Soaring in a Weak Market

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

8 Stocks Under $10 Making Big Moves

8 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Under $10 Moving Higher

These under-$10 stocks are making huge-percentage moves to the upside today.

5 Drug Stock Losers of 2010

Clinical trial failures, poor sales and crushing debt pummeled shares of Vermillion, Oxigene and Angiotech in 2010.

Best and Worst Drug Stocks in Q3

KV Pharmaceuticals was the best-performing biotech and drug stock in the third quarter, while Icagen was the worst.

Biotech Stock Mailbag - 2Q Updates

Biotech columnist Adam Feuerstein answers readers' questions about drug and health care-related firms.